Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed to perform home infusion include the drug (for example, antivirals, immune globulin), equipment (for example, a pump), and supplies (for example, tubing and catheters). Similarly, nursing services are necessary to train and educate the patient and caregivers on the safe administration of infusion drugs in the home. Visiting nurses often play an important role in home infusion. Nurses typically train the patient or caregiver to self-administer the drug, educate on side effects and goals of therapy, and visit periodically to assess the infusion site and provide dressing changes. The home infusion process typically requires coordination among multiple entities, including patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if applicable, home health agencies.
Market Dynamics
Key players operating in the global home infusion therapy market are focusing on adoption of inorganic growth strategies such as investments which are expected to drive the market growth during the forecast period. For instance, in May 2019, Nipro Corporation announced to invest US$ 21 million in JMI Syringes & Medical Devices Ltd., a medical devices company, in order to expand its disposable syringe portfolio and become its strategic partner.
Key features of the study:
Detailed Segmentation:
Global Home Infusion Therapy Market, By Product Type:
Global Home Infusion Therapy Market, By Application:
Global Home Infusion Therapy Market, By Region:
Company Profiles
“*” marked represents similar segmentation in other categories in the respective section.
Market Dynamics
Key players operating in the global home infusion therapy market are focusing on adoption of inorganic growth strategies such as investments which are expected to drive the market growth during the forecast period. For instance, in May 2019, Nipro Corporation announced to invest US$ 21 million in JMI Syringes & Medical Devices Ltd., a medical devices company, in order to expand its disposable syringe portfolio and become its strategic partner.
Key features of the study:
- This report provides in-depth analysis of the global home infusion therapy market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global home infusion therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Becton, Dickinson and Company, B. Braun Melsungen AG, Nipro Corporation, ICU Medical, Inc., Baxter International Inc., Terumo Corporation, Smiths Medical, Fresenius Kabi AG, Eli Lilly and Company, JMS Co. Ltd., and NewIV Medical, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global home infusion therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global home infusion therapy market.
Detailed Segmentation:
Global Home Infusion Therapy Market, By Product Type:
- Infusion Pumps
- Ambulatory Infusion Pumps
- Insulin Pumps
- Syringe Pumps
- Elastomeric Pumps
- Patient Controlled Analgesics (PCA)
- Volumetric Pumps
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
Global Home Infusion Therapy Market, By Application:
- Chemotherapy
- Diabetes
- Hydration Therapy
- Pain Management
- Post-transplant Therapies
- Parenteral Nutrition Therapy
- Others
Global Home Infusion Therapy Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Becton, Dickinson and Company*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- B. Braun Melsungen AG
- Nipro Corporation
- ICU Medical, Inc.
- Baxter International Inc.
- Terumo Corporation
- Smith’s Medical
- Fresenius Kabi AG
- Eli Lilly and Company
- JMS Co. Ltd.
- NewIV Medical, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Home Infusion Therapy Market - Impact of Coronavirus (COVID-19) Pandemic
5. Global Home Infusion Therapy Market, By Product Type, 2016 - 2027, (US$ Mn)
6. Global Home Infusion Therapy Market, By Application, 2016 - 2027, (US$ Mn)
7. Global Home Infusion Therapy Market, By Region, 2016 - 2027, (US$ Mn)
8. Competitive Landscape
9. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Nipro Corporation
- ICU Medical, Inc.
- Baxter International Inc.
- Terumo Corporation
- Smith’s Medical
- Fresenius Kabi AG
- Eli Lilly and Company
- JMS Co. Ltd.
- NewIV Medical, Inc.